Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more
Market Cap & Net Worth: Baird Medical Investment Holdings Limited (BDMD)
Baird Medical Investment Holdings Limited (NASDAQ:BDMD) has a market capitalization of $76.76 Million ($76.76 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26457 globally and #8949 in its home market, demonstrating a -27.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Baird Medical Investment Holdings Limited's stock price $2.09 by its total outstanding shares 36725899 (36.73 Million).
Baird Medical Investment Holdings Limited Market Cap History: 2024 to 2026
Baird Medical Investment Holdings Limited's market capitalization history from 2024 to 2026. Data shows change from $279.12 Million to $76.76 Million (-68.55% CAGR).
Index Memberships
Baird Medical Investment Holdings Limited is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #699 of 976 |
Weight: Baird Medical Investment Holdings Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Baird Medical Investment Holdings Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Baird Medical Investment Holdings Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.54x
Baird Medical Investment Holdings Limited's market cap is 7.54 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
22.41x
Baird Medical Investment Holdings Limited's market cap is 22.41 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $279.12 Million | $37.04 Million | $12.45 Million | 7.54x | 22.41x |
Competitor Companies of BDMD by Market Capitalization
Companies near Baird Medical Investment Holdings Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Baird Medical Investment Holdings Limited by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Baird Medical Investment Holdings Limited Historical Marketcap From 2024 to 2026
Between 2024 and today, Baird Medical Investment Holdings Limited's market cap moved from $279.12 Million to $ 76.76 Million, with a yearly change of -68.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $76.76 Million | +53.68% |
| 2025 | $49.95 Million | -82.11% |
| 2024 | $279.12 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Baird Medical Investment Holdings Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $76.76 Million USD |
| MoneyControl | $76.76 Million USD |
| MarketWatch | $76.76 Million USD |
| marketcap.company | $76.76 Million USD |
| Reuters | $76.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.